News & Updates

Show Multimedia Only

UK Biobank: As hard water levels increase, so does the burden of eczema

26 Aug 2022 by

Exposure to domestic hard water in high concentrations appears to go with a corresponding increase in the prevalence of eczema in adults, as reported in a UK study.

26 Aug 2022

Brepocitinib cream works in mild-to-moderate atopic dermatitis

25 Aug 2022

The topical cream brepocitinib, a small molecule tyrosine kinase 2, appears to be effective in the treatment of mild-to-moderate atopic dermatitis while being well tolerated, according to the results of a double-blind, dose-ranging phase IIb trial.

25 Aug 2022

OASIS-1: Thumbs up for mirikizumab in moderate-to-severe plaque psoriasis

23 Aug 2022 by

The interleukin (IL)-23 inhibitor mirikizumab demonstrates superior efficacy in the treatment of patients with moderate-to-severe plaque psoriasis as compared with placebo, with initial responses during induction preserved through the maintenance phase, according to the results of the phase III OASIS-1 trial.

23 Aug 2022

Hair loss common after COVID-19 infection

19 Aug 2022 by

There appears to be an increased risk of hair loss – a phenomenon called telogen effluvium – after COVID-19 infection.

19 Aug 2022

DPP4i-associated bullous pemphigoid shows distinct skin cytokine profile

13 Aug 2022

The cutaneous cytokine expression is different in patients with dipeptidyl peptidase 4 inhibitor (DPP4i)-associated bullous pemphigoid (BP), as opposed to those with typical BP, reports a new study.

13 Aug 2022

Secukinumab 300 mg leads to sustained improvements in PsA symptoms

12 Aug 2022 by

Treatment with secukinumab 300 mg significantly improves symptoms of biologic-naïve patients with psoriatic arthritis (PsA) compared with placebo, results from the CHOICE study have shown.

12 Aug 2022

Hidradenitis suppurativa: Treatment by specialist, with biologics dictate satisfaction

07 Aug 2022

Among patients with hidradenitis suppurativa, treatment satisfaction is high for those who are treated by a dermatologist and receive a biologic medication, a study has found.

07 Aug 2022

Topical isotretinoin eases symptoms in recessive congenital ichthyosis

06 Aug 2022

A phase IIb trial has found that TMB-001, a novel topical isotretinoin ointment, can safely improve symptoms of hyperkeratosis and widespread scaling in patients with X-linked recessive or autosomal recessive congenital ichthyosis (CI).

06 Aug 2022

FLASH: Light-activated hypericin ointment gets high marks in early-stage mycosis fungoides

03 Aug 2022 by

Photodynamic therapy using topically applied hypericin 0.25% is effective against early-stage patch and plaque lesions in patients with mycosis fungoides−cutaneous T-cell lymphoma, while having a favourable safety profile, as shown in the phase III FLASH trial.

03 Aug 2022

Antenatal vitamin D supplementation may curb risk of infant eczema

01 Aug 2022 by

Infants born to mothers who popped vitamin D during pregnancy are less likely to develop atopic eczema compared with their counterparts whose mothers received placebo, as shown in the UK Maternal Vitamin D Osteoporosis Study (MAVIDOS).

01 Aug 2022